Company logo

ETON - Eton Pharmaceuticals, Inc.

NASDAQ -> Healthcare -> Biotechnology
Deer Park, United States
Type: Equity

ETON price evolution
ETON
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $21.39 $22.07 $21.57 $14.71
Short term investments
Net receivables $3.41 $3.5 $3.08 $2.87
Inventory $0.91 $1.05 $0.82 $0.44
Total current assets $26.84 $27.16 $26.33 $19.12
Long term investments
Property, plant & equipment $0.15 $0.15 $0.2 $0.23
Goodwill & intangible assets $4.74 $4.21 $4.39 $4.57
Total noncurrent assets $4.9 $4.37 $4.6 $4.81
Total investments
Total assets $31.74 $31.53 $30.93 $23.93
Current liabilities
Accounts payable $1.85 $1.71 $2.3 $1.23
Deferred revenue
Short long term debt $5.38 $1.54 $1.54 $1.34
Total current liabilities $16.24 $10.39 $9.59 $7.49
Long term debt $0.02 $4.24 $4.62 $5.19
Total noncurrent liabilities $0.02 $4.24 $4.62 $5.19
Total debt $5.4 $5.78 $6.16 $6.53
Total liabilities $16.26 $14.63 $14.21 $12.69
Shareholders' equity
Retained earnings -$104.07 -$101.81 -$101.23 -$105.79
Other shareholder equity
Total shareholder equity $15.48 $16.89 $16.73 $11.24
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $21.39 $16.3 $14.41 $21.3
Short term investments
Net receivables $3.41 $1.85 $5.47 $0.05
Inventory $0.91 $0.56 $0.55 $1.24
Total current assets $26.84 $20 $23.6 $24.7
Long term investments
Property, plant & equipment $0.15 $0.26 $0.22 $1
Goodwill & intangible assets $4.74 $4.75 $3.62 $0.57
Total noncurrent assets $4.9 $5.03 $3.86 $1.62
Total investments
Total assets $31.74 $25.03 $27.46 $26.32
Current liabilities
Accounts payable $1.85 $1.69 $1.77 $2.34
Deferred revenue
Short long term debt $5.38 $1.03 $1.42 $0.28
Total current liabilities $16.24 $6.46 $4.56 $3.79
Long term debt $0.02 $5.38 $5.28 $6.86
Total noncurrent liabilities $0.02 $5.49 $5.28 $6.86
Total debt $5.4 $6.52 $6.7 $7.14
Total liabilities $16.26 $11.95 $9.84 $10.66
Shareholders' equity
Retained earnings -$104.07 -$103.13 -$94.11 -$92.16
Other shareholder equity
Total shareholder equity $15.48 $13.08 $17.63 $15.66
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $8.31 $7.03 $12 $5.3
Cost of revenue $3.68 $2.63 $2.31 $1.96
Gross Profit $4.63 $4.4 $9.68 $3.35
Operating activities
Research & development $1.05 $0.61 $1.13 $0.54
Selling, general & administrative $4.58 $4.34 $4.67 $5.34
Total operating expenses $5.62 $4.95 $5.8 $5.88
Operating income -$0.99 -$0.55 $3.88 -$2.53
Income from continuing operations
EBIT -$2.79 -$0.55 $4.68 -$2.53
Income tax expense $0.25
Interest expense -$0.78 $0.03 $0.12 $0.13
Net income
Net income -$2.26 -$0.58 $4.56 -$2.66
Income (for common shares) -$2.26 -$0.58 $4.56 -$2.66
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $32.64 $22.89 $23.33 $0.04
Cost of revenue $10.58 $6.93 $2.62 $0.29
Gross Profit $22.06 $15.96 $20.71 -$0.25
Operating activities
Research & development $3.32 $4 $6.24 $14.1
Selling, general & administrative $18.93 $18.58 $14.47 $12.76
Total operating expenses $22.25 $22.58 $20.7 $26.86
Operating income -$0.19 -$6.62 $0.01 -$27.11
Income from continuing operations
EBIT -$1.19 -$8.26 -$0.95 -$27.97
Income tax expense $0.25
Interest expense -$0.5 $0.76 $1.01
Net income
Net income -$0.94 -$9.02 -$1.96 -$27.97
Income (for common shares) -$0.94 -$9.02 -$1.96 -$27.97
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$2.26 -$0.58 $4.56 -$2.66
Operating activities
Depreciation $0.28 $0.2 $0.21 $0.21
Business acquisitions & disposals
Stock-based compensation $0.75 $0.73 $0.79 $0.87
Total cash flows from operations $0.39 $0.87 $7.1 -$1.55
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$0.78
Financing activities
Dividends paid
Sale and purchase of stock -$0.09 $0.02 $0.14 $0.13
Net borrowings -$0.39 -$0.39 -$0.39
Total cash flows from financing -$0.29 -$0.37 -$0.25 -$0.05
Effect of exchange rate
Change in cash and equivalents -$0.68 $0.5 $6.86 -$1.6
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$0.94 -$9.02 -$1.96 -$27.97
Operating activities
Depreciation $0.9 $1.77 $0.46 $0.65
Business acquisitions & disposals
Stock-based compensation $3.14 $4.22 $3.38 $2.58
Total cash flows from operations $6.82 $4.82 -$4.72 -$22.35
Investing activities
Capital expenditures -$0.04 $0.69 -$0.05
Investments
Total cash flows from investing -$0.78 -$2.79 -$2.56 -$0.05
Financing activities
Dividends paid
Sale and purchase of stock $0.2 $0.25 $0.54 $29.15
Net borrowings -$1.16 -$0.39 -$0.15 $2.48
Total cash flows from financing -$0.96 -$0.13 $0.39 $31.63
Effect of exchange rate
Change in cash and equivalents $5.08 $1.9 -$6.89 $9.23
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding N/A
Revenue $32.64M
EBITDA -$291.00K
EBIT -$1.19M
Net Income -$936.00K
Revenue Q/Q -9.13%
Revenue Y/Y 42.60%
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA -3.17%
ROE -6.21%
Debt/Equity 1.05
Net debt/EBITDA 17.61
Current ratio 1.65
Quick ratio 1.60